|
|
- 2016
不同时期抗病毒治疗对艾滋病患者耐药产生的影响分析
|
Abstract:
| [1] | Xing H, Ruan Y, Li J, et al. HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients[J]. PLoS One, 2013, 8(2): e54917. doi: 10.1371/journal.pone.0054917. Epub 2013 Feb 6. |
| [2] | 崔卫国, 薛秀娟, 刘佳, 等. 河南省沈丘县抗病毒治疗者HIV耐药株流行状况调查[J]. 中华流行病学杂志, 2013, 34(3): 218-220. CUi Weiguo, XUE Xiujuan, LIU Jia, et al. A cross-sectional study on the prevalence of HIV drug resistance in patients receiving antiretroviral treatment in Shenqiu county, Henan province[J]. Chinese Journal of Epidemiology, 2013, 34(3): 218-220. |
| [3] | Mwesigire DM, Wu AW, Martin F, et al. Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study[J]. BMC Health Serv Res, 2015,15: 292. doi: 10.1186/s12913-015-0959-0. |
| [4] | Hong SY, Jonas A, DeKlerk M, et al. Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia[J]. J Acquir Immune Defic Syndr, 2015, 68(4): 463-471. |
| [5] | Hosseinipour MC, Gupta RK, Van Zyl G, et al. Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings[J]. J Infect Dis, 2013, 207(Suppl 2): S49-56. |
| [6] | Wang J, Wang Z, Liao L, et al. Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China[J]. Sci Rep, 2015, 5: 14823. doi: 10.1038/srep14823. |
| [7] | 中国疾病预防控制中心. 国家免费艾滋病抗病毒治疗手册[M]. 3版.北京: 人民卫生出版社, 2012. |
| [8] | Wang J, He C, Hsi JH, et al. Virological outcomes and drug resistance in Chinese patients after 12 months of 3TC-based first-line antiretroviral treatment, 2011-2012[J]. PLoS One, 2014, 9(2): e88305. doi: 10.1371/journal.pone.0088305. eCollection 2014. |
| [9] | 丁佩佩, 何纲, 陈晓华, 等. 不同CD4+细胞水平HIV感染者抗病毒治疗的疗效及药物不良反应分析[J].中国医师杂志, 2015, 17(1): 52-57. DING Peipei, HE Gang, CHEN Xiaohua, et al. Efficacy and side effects of HAART in HIV-infected patients with different CD4 cell counts[J]. Journal of Chinese Physician, 2015, 17(1): 52-57. |
| [10] | Liao L, Xing H, Su B, et al. Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China[J]. AIDS, 2013, 27(11): 1815-1824. |
| [11] | 孙定勇, 王奇, 杨文杰, 等. 河南省2003-2009年艾滋病抗病毒治疗患者生存状况分析[J]. 中华流行病学杂志, 2012, 33(2): 181-184. SUN Dingyong, WANG Qi, YANG Wenjie, et al. Survival analysis on AIDS antiretroviral therapy in Henan province during 2003-2009[J]. Chinese Journal of Epidemiology, 2012, 33(2): 181-184. |
| [12] | Kaleebu P, Kirungi W, Watera C. Virological response and antiretroviral drug resistance emerging during antiretroviral therapy at three treatment centers in uganda[J]. PLoS One, 2015, 10(12): e0145536. doi: 10.1371/journal.pone.0145536. eCollection 2015. |
| [13] | 杨文杰, 樊盼英, 梁妍, 等. 2008-2013年河南省艾滋病患者抗病毒治疗对HIV的抑制效果及其影响因素分析[J]. 中华预防医学杂志, 2015, 49(1): 13-20. YANG Wenjie, FAN Panying, LIANG Yan, et al. Analysis on HIV suppression effect after initiating antiretroviral treatment and related factors among AIDS patients in Henan province during 2008 and 2013[J]. Chinese Journal of Preventive Medicine, 2015, 49(1): 13-20. |
| [14] | Jiamsakul A, Sungkanuparph S, Law M, et al. HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia[J]. J Int AIDS Soc, 2014, 17: 19053. doi: 10.7448/IAS.17.1.19053. eCollection 2014. |
| [15] | Jain V, Byonanebye DM, Amanyire G, et al. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda[J]. AIDS, 2014, 28(15): 2241-2249. |
| [16] | Xing H, Ruan Y, Hsi JH, et al. Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12[J]. J Antimicrob Chemother, 2015, 70(7): 2097-2103. |
